Unknown

Dataset Information

Optimizing a therapy for opiate use disorders: Characterizing ondansetron pharmacokinetics in blood and brain.


ABSTRACT: Administration of a widely used 5-hydroxytryptamine receptor (5HT3A R) antagonist (ondansetron) potently inhibited the development of experimentally induced opioid dependence and withdrawal responses in mice and humans. However, in several studies examining withdrawal symptoms in subjects with chronic opioid use disorders (OUDs), ondansetron exhibited reduced or absent efficacy. Because attenuation of opioid withdrawal symptomatology is mediated within the brain, this study examined single-dose ondansetron pharmacokinetics in the blood and brain of mice. We demonstrate that ondansetron concentrations in the brain (Cbrain ng/mg) are 1000-fold lower than the blood concentrations (Cblood ng/ml) and decrease rapidly after ondansetron administration; and that a

SUBMITTER: Wu M 

PROVIDER: S-EPMC9926069 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature